The FDA has issued draft guidance on the use of “Exculpatory Language in Informed Consent” agreements. The document applies to non-exempt hu
Continue Reading FDA Issues Draft Guidance on Informed Consent Language
Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation
The FDA has issued draft guidance on the use of “Exculpatory Language in Informed Consent” agreements. The document applies to non-exempt hu…
Continue Reading FDA Issues Draft Guidance on Informed Consent Language